TLX

Telix Pharmaceuticals
TLX

6 hedge funds and large institutions have $799K invested in Telix Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$451K
2
+$170K
3
+$94.4K
4
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
+$19.2K
5
EWA
EverSource Wealth Advisors
Alabama
+$2.3K

Top Sellers

1
-$1.32K
Name Holding Trade Value Shares
Change 		Change in
Stake
AA
1
ABC Arbitrage
France
$451K
PAG
2
Private Advisor Group
New Jersey
$170K
Morgan Stanley
3
Morgan Stanley
New York
$94.4K
UBS Group
4
UBS Group
Switzerland
$61.2K
RhumbLine Advisers
5
RhumbLine Advisers
Massachusetts
$19.2K
EWA
6
EverSource Wealth Advisors
Alabama
$2.3K